View Clinical Trial (Medical Research Study)
Connect® MM- The Multiple Myeloma Disease Registry
| City: |
|
Hyannis |
| State: |
|
Massachusetts |
| Zip Code: |
|
02601 |
| Conditions: |
|
Multiple Myeloma |
| Purpose: |
|
The purpose of the Connect® MM Registry is to explore the natural history and real world
management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide
unique insights into the management of MM and the impact of this hematologic disorder on
patients.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Newly diagnosed with symptomatic MM within 2 months of enrollment in Connect® MM
registry
- Age ≥18 years
- Able to read and speak English
- Willing and able to provide signed informed consent
- Agrees to complete patient assessment questionnaires either alone or with minimal
assistance from caregivers and/or trained site personnel
Exclusion Criteria:
• Participation in a clinical study in which study treatment is blinded
|
| NCT ID: |
|
NCT01081028 |
| Primary Contact: |
|
Study Director
Mohamad Hussein, MD
Celgene Corporation
Kristen Sullivan
Phone: 1-913-266-0329
Email: connectmm@celgene.com
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Hyannis, Massachusetts 02601
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|